Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Getinge ABLTS:0GZV -0.41%73 Days Payable is 47.79 as of Jun. 2026, which is 3% below its 10-year median of 49.25. GuruFocus rates LTS:0GZV with a GF Score™ of 73/100 and a GF Value™ of kr206.02 (Modestly Overvalued). The stock has 10 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Getinge AB ranks worse than 73.84% on this metric.
Getinge AB's average Accounts Payable for the
three
months ended in Jun. 2026 was kr2,077 Mil. Getinge AB's Cost of Goods Sold for the
three
months ended in Jun. 2026 was kr3,965 Mil.
Hence, Getinge AB's Days Payable for the
three
months ended in Jun. 2026 was 47.79.
The historical rank and industry rank for Getinge AB's Days Payable or its related term are showing as below:
LTS:0GZV'
s Days Payable Range Over the Past 10 Years
Min: 41.6 Med: 49.25 Max: 65.45
Current: 42.48
During the past 13 years, Getinge AB's highest Days Payable was 65.45. The lowest was 41.60. And the median was 49.25.
LTS:0GZV's Days Payable is ranked worse than 73.84% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 67.87
vs LTS:0GZV: 42.48
Getinge AB's Days Payable
increased
from Jun. 2025 (45.29) to Jun. 2026 (47.79).
It may suggest that Getinge ABdelayed paying its suppliers.
Getinge AB Days Payable Related Terms
Getinge AB Days Payable Historical Data
* Premium members only.
The historical data trend for Getinge AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0GZV vs ABT, SYK, MDT: Days Payable Comparison
For the Medical Devices subindustry, Getinge AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Getinge AB Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Getinge AB's Days Payable distribution charts can be found below:
* The bar in red indicates where Getinge AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Getinge AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Getinge AB (LTS:0GZV) has a Days Payable of 47.79 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Getinge AB and its competitors. This is near median its historical median of 49.25. Over the past decade, Getinge AB's Days Payable has ranged from 41.60 to 65.45. According to the industry distribution chart, Getinge AB ranks #587 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 73.8%.
Is Getinge AB's Days Payable too high?
Getinge AB's current Days Payable of 47.79 is near median its 10-year median of 49.25. Over the past 10 years, this metric has ranged from a low of 41.60 to a high of 65.45. The Medical Devices & Instruments industry median Days Payable is 67.87. Getinge AB's value of 47.79 is 29.6% below this industry median. Based on the distribution chart, Getinge AB ranks #587 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Getinge AB has a GF Score™ of 73/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Getinge AB's Days Payable compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Getinge AB ranks #587 out of 795 companies for Days Payable. This places Getinge AB in the lower half of its industry. The industry median Days Payable is 67.87. Getinge AB's value of 47.79 is 29.6% below this benchmark. Historically, Getinge AB's own Days Payable has ranged from 41.60 to 65.45 over the past decade. While the company's 10-year median is 49.25 vs. the industry median of 67.87, Getinge AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.87, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Getinge AB's current Days Payable of 47.79 is 29.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Getinge AB and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Getinge AB's current Days Payable is 47.79, which is near median its own 10-year median of 49.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Getinge AB stock overvalued right now?
Based on GuruFocus' analysis, Getinge AB (LTS:0GZV) is currently considered Modestly Overvalued. The stock's GF Value™ is kr206.02, compared to a current price of kr228.55 — trading 10.9% above its estimated fair value. The current Days Payable is 47.79, which is near median its 10-year median of 49.25 and 29.6% below the Medical Devices & Instruments industry median of 67.87. Getinge AB's overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Getinge AB (LTS:0GZV), the current Days Payable is 47.79 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Getinge AB (LTS:0GZV) Overvalued in 2026?
Based on GuruFocus' analysis, Getinge AB stock appears to be overvalued.
The current stock price of kr228.55 is trading 10.9% above its estimated GF Value™ of kr206.02.
GuruFocus considers Getinge AB to be Modestly Overvalued.
Key valuation signals for LTS:0GZV:
Days Payable: 47.79 (near median its 10-year median of 49.25)
GF Value™: kr206.02 vs. price of kr228.55 (10.9% above fair value)
Industry Position: 29.6% below the Medical Devices & Instruments median (#587 of 795)
No single metric tells the full story. See the LTS:0GZV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (35%), and life sciences (13%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales, Europe, Middle East, and Africa 35%, and Asia-Pacific the remaining 25%.
73GF Score
Get the complete analysis for LTS:0GZV
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0GZV has been successfully added to your 
